Vividair News & Articles

From monthly archives: January 2016

We are pleased to present below all posts archived in 'January 2016'. If you still can't find what you are looking for, try using the search box.

VividAir helps in the fight against drug-resistant TB

Multidrug-Resistant Tuberculosis, also known as MDR-TB, is a variation of TB that does not respond to the standard first-line antibiotics isoniazid and rifampicin – the two most powerful anti-TB drugs on the market.

Extensively Drug-Resistant TB, XDR-TB, is another, more serious form of multidrug-resistant tuberculosis, with additional resistance to more anti-TB drugs.

The success rate for treatment of MDR-TB is less than 50%, while the success rate for treatment of XDR-TB is even lower, at just 20%. South Africa has the highest number of cases of XDR-TB in the world.

Read the rest of entry »

Subscription

Get the latest updates in your email box automatically.

Search

Archive

CloseCOVID-19 Corona Virus South African Resource Portal